Related Experiment Video

Updated: Nov 28, 2025

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.7K

Impact of Modifiable Risk Factors on Long-Term Outcomes after Coronary Artery Bypass Surgery

Dror B Leviner1, Barak Zafrir2, Ronen Jaffe2

  • 1Department of Cardiothoracic Surgery, Carmel Medical Center Cardiovascular Center, Haifa, Israel.

The Thoracic and Cardiovascular Surgeon
|December 1, 2020
PubMed

Insights

Optimizing modifiable risk factors like diabetes, hyperlipidemia, and smoking after coronary artery bypass grafting (CABG) is crucial. Addressing these factors significantly reduces the risk of future coronary events and improves long-term cardiovascular health.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Preventive Medicine

Background:

  • Suboptimal risk factor control and secondary prevention are common in patients after coronary artery bypass grafting (CABG).
  • This can negatively impact clinical outcomes and long-term prognosis following CABG.
  • Identifying and managing modifiable risk factors is essential for improving patient care.

Purpose of the Study:

  • To evaluate potentially modifiable cardiovascular risk factors in patients undergoing CABG.
  • To investigate the association between these risk factors and long-term coronary events post-CABG.

Main Methods:

  • Preoperative cardiovascular risk factors were recorded in 1,125 patients undergoing CABG.
  • Long-term coronary events (acute coronary syndrome or revascularization) were tracked over a mean follow-up of 93 months.
  • Statistical analysis identified independent predictors of future coronary events.

Main Results:

  • Hypertension (71%), hyperlipidemia (67%), and diabetes (42%) were highly prevalent; only 8% had no risk factors.
  • Active smoking, diabetes, and hyperlipidemia were independent predictors of long-term coronary events after CABG.
  • The cumulative presence of these risk factors showed a progressive increase in event risk.

Conclusions:

  • Preoperative diabetes, hyperlipidemia, and smoking are independently associated with long-term coronary events post-CABG.
  • These modifiable risk factors also show a cumulative effect on long-term risk.
  • Emphasizes the critical need for early identification and management of these risk factors to enhance cardiovascular health after CABG.
Abstract

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.6K
Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.0K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
688
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
484
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
152
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
133
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
145
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
174